Dermatology
1 drug is in development for Plaque Psoriasis.
- Companies
- 1
- Clinical trials
- 45
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Plaque Psoriasis pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 2(1)
| Drug | Company |
|---|---|
| orka-002 | Oruka Therapeutics, Inc. (ORKA) |
About this indication
Plaque Psoriasis context
Dermatology·MeSH: Psoriasis (D011565)
Narrower concept of MeSH descriptor Psoriasis
Prevalence
3000.0 / 100K
Incidence
78.0 / 100K/yr
Frequently asked questions
How many drugs are in development for Plaque Psoriasis?
BioSniper tracks 1 drug in development for Plaque Psoriasis across 1 company.
How many clinical trials target Plaque Psoriasis?
There are 45 clinical trials targeting Plaque Psoriasis tracked by BioSniper.
What is the prevalence of Plaque Psoriasis?
The estimated prevalence of Plaque Psoriasis is approximately 3000.0 per 100,000 population.